Moderna Inc.
Juan Andres (Chief Operating Officer) reports MRNA insider transactions
AI-generated summary
Juan Andres, Chief Operating Officer of Moderna Inc., received a grant of 7,898 stock options and a grant of 16,955 restricted stock units on November 5, 2026. The awards are held directly.
Key facts
- Insider
- Juan Andres · Chief Operating Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | A · grantStock Option (Right to Buy)Footnotes F1 | +7,898 | $0.00 | $0.00 | 7,898 | Direct |
| Nov 5, 2026 | A · grantRestricted Stock UnitsFootnotes F2, F3 | +16,955 | $0.00 | $0.00 | 16,955 | Direct |
Footnotes
- F1 25% of this option will vest and become exercisable on November 5, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F2 Restricted stock units convert into common stock on a one-for-one basis.
- F3 25% of the shares subject to this restricted stock unit award will vest on November 5, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
More MRNA filings
- 10-Q
Filed Nov 6, 2026
- 8-K
Filed Nov 6, 2026
- SC 13G/A
Filed Nov 5, 2026
- 4
Filed Oct 16, 2026
- 144
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.